Nikolaos Galanakis: Percutaneous Mechanical Thrombectomy has Emerged as a Valuable Treatment Option in Acute Limb Ischemia
Nikolaos Galanakis, Assistant Professor of Interventional Radiology Medical School / University of Crete, shared a post on LinkedIn:
“IRchalenge day 4…
Percutaneous mechanical thrombectomy (PMT) has emerged as a valuable treatment option in acute limb ischemia (ALI), offering rapid restoration of arterial flow while minimizing the risks associated with open surgery or prolonged thrombolysis. By mechanically fragmenting and removing thrombotic material, PMT provides rapid reperfusion, a key determinant for limb salvage and prevention of ischemic complications.
A 67-year-old male presented with ALI due to acute thrombosis of a femoropopliteal bypass graft, originally created for treatment of a popliteal artery aneurysm. The patient underwent percutaneous pharmacomechanical thrombectomy using the AngioJet device and angioplasty, achieving significant restoration of arterial flow.
This is the power of IR. Keep the momentum going at CIRSE2025!”
Find more on Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia